Perrigo Co PLC (PRGO)

PRGO (NYSE:Drugs) EQUITY
$97.07
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | PRGO Avg Daily Volume: 2,663,700
Last Update: 05/05/16 - 4:02 PM EDT
Volume: 0
YTD Performance: -32.92%
Open: $0.00
Previous Close: $97.07
52 Week Range: $94.77 - $200.96
Oustanding Shares: 143,198,631
Market Cap: 13,704,108,987
6-Month Chart
TheStreet Ratings Grade for PRGO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 10 10 8
Moderate Buy 0 0 0 0
Hold 10 8 8 7
Moderate Sell 1 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.35 1.89 1.89 1.93
Latest Dividend: 0.14
Latest Dividend Yield: 0.61%
Dividend Ex-Date: 05/25/16
Price Earnings Ratio: 98.66
Price Earnings Comparisons:
PRGO Sector Avg. S&P 500
98.66 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-32.53% -48.40% -18.59%
GROWTH 12 Mo 3 Yr CAGR
Revenue -39.80 -1.00 0.00
Net Income -95.60 -1.00 0.00
EPS -95.80 -1.00 0.00
Earnings for PRGO:
EBITDA 0.00B
Revenue 2.77B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $1.73 $2.24 $8.45 $9.93
Number of Analysts 10 18 11 20
High Estimate $1.87 $2.55 $9.45 $11.00
Low Estimate $1.71 $1.95 $8.20 $8.61
Prior Year $1.85 $2.18 $7.59 $8.45
Growth Rate (Year over Year) -6.32% 2.57% 11.29% 17.50%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Bruce Kamich

 | May 4, 2016 | 4:50 PM EDT

Perrigo could have an oversold bounce at any time as bears turn aggressive, but nothing right now indicates a price bottom.

By

Doug Kass

 | May 4, 2016 | 12:40 PM EDT
-- The year-end financials that VRX filed on Friday disclosed a dangerously overleveraged balance sheet. Valeant has $30.3 billion in long-term debt, while goodwill totals $18.6 billion and 'intangibles' add up to $23.2 billion. In essence, the company paid up big time for a large amount of mergers and acquisitions -- and funded those transactions with a huge debt load. -- Valeant had $6 billion of book value at year's end, down $500 million from the prior quarter. Subtracting goodwill takes the company to $12.5 billion of negative book value. And if we 'guesstimate' that the value of VRX's intangible assets ultimately gets halved, the company's tangible net worth drops to  a neg
By

Doug Kass

 | May 2, 2016 | 10:18 AM EDT
The ultimate value of the company's businesses (calculated by cash flows and profits) could be insufficient relative to its liabilities to provide any value at all. The year-end financials that VRX filed on Friday disclosed a dangerously overleveraged balance sheet. Valeant has $30.3 billion in long-term debt, while goodwill totals $18.6 billion and "intangibles" add up to $23.2 billion. In essence, the company paid up big time for a large amount of mergers and acquisitions -- and funded those transactions with a huge debt load. Valeant had $6 billion of book value at year's end, down $500 million from the prior quarter. Subtracting goodwill takes the company to $12.5 billion of negative book value. And if we "guesstimate" that the value of VRX's intangible assets ultimately gets halved, the company's tangible net worth drops to  a negative $24 billion. Combined with Valeant's $30 billion of debt, that translates into a distressed and foundering company. VRX said its $30.5 billion of intangible assets represen
By

Paul Price

 | May 1, 2016 | 2:00 PM EDT

Get paid very well for making the 'uncomfortable' play others are afraid to take. 

By

Paul Price

 | Apr 29, 2016 | 8:00 AM EDT

Get paid very well for making the 'uncomfortable' play others are afraid to take. 

By

Jim Cramer

 | Apr 26, 2016 | 7:20 AM EDT

Everything about the CEO's move to Valeant stinks.

bearishPerrigo downgraded at Jefferies

Apr 26, 2016 | 7:05 AM EDT

PRGO was downgraded to Hold, Jefferies said. $112 price target. Valuation call, given the company's new guidance. 

By

Bob Byrne

 | Apr 26, 2016 | 7:00 AM EDT

Trying to exploit the PRGO-VRX dealings could leave you with a losing hand.

By

Jim Cramer

 | Apr 25, 2016 | 11:44 AM EDT

Jim Cramer says there are still a lot of questions around Valeant, which named a new CEO, Joseph Papa today.

By

James Passeri

 | Apr 25, 2016 | 10:40 AM EDT

Valeant delighted shareholders Monday with news that Perrigo's Joseph Papa is getting into the driver's seat. 

$550 million to buy market on close.

breadth is weak and fear is rising in front NFP. we will add protection. BOUGHT SPY MAY 20...
Market has lost early but slight gains, and now sports small losses. Equities don't seem ...
Is to find Yale Liebowitz's photo (he was Pablo's best friend in first grade) in The Donal...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.